Both AD and LATE-NC with ADNC cases had a significant increase of pTau (T231)/total Tau ratios (“pTau(T231)/tTau”), consistent with AD neuropathological changes observed by IHC (Fig. 1c). This evidence concerns the gene MAPT and Alzheimer disease.